SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004450
Filing Date
2018-05-09
Accepted
2018-05-09 13:58:24
Documents
54
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ecyt-20180331x10q.htm 10-Q 1273991
2 EX-10.1 ecyt-20180331ex10194b733.htm EX-10.1 37597
3 EX-31.1 ecyt-20180331ex311ddeaa2.htm EX-31.1 19936
4 EX-31.2 ecyt-20180331ex312411bb8.htm EX-31.2 18041
5 EX-32.1 ecyt-20180331ex321f9fc0f.htm EX-32.1 15415
  Complete submission text file 0001558370-18-004450.txt   4849820

Data Files

Seq Description Document Type Size
6 EX-101.INS ecyt-20180331.xml EX-101.INS 953994
7 EX-101.SCH ecyt-20180331.xsd EX-101.SCH 34871
8 EX-101.CAL ecyt-20180331_cal.xml EX-101.CAL 31230
9 EX-101.DEF ecyt-20180331_def.xml EX-101.DEF 143407
10 EX-101.LAB ecyt-20180331_lab.xml EX-101.LAB 319068
11 EX-101.PRE ecyt-20180331_pre.xml EX-101.PRE 276077
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 18817691
SIC: 2834 Pharmaceutical Preparations